`
`Paper No. ______
`
`
`
`
`By: Eric W. Dittmann (PH-drreddys-helsinn-PGR@paulhastings.com)
`
`Naveen Modi (PH-drreddys-helsinn-PGR@paulhastings.com)
` Michael A. Stramiello, Ph.D. (PH-drreddys-helsinn-PGR@paulhastings.com)
`
`Thomas L. Irving (tom.irving@finnegan.com)
` Mark E. Waddell (mwaddell@loeb.com)
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`DR. REDDY’S LABORATORIES, LTD. and
`DR. REDDY’S LABORATORIES, INC.,
`Petitioner
`
`v.
`
`HELSINN HEALTHCARE S.A. and
`ROCHE PALO ALTO LLC,
`Patent Owner
`
`
`
`
`
`
`
`
`Case PGR2016-00008
`Patent 9,173,942
`
`
`
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`Patent No. 9,173,942
`
`Helsinn Healthcare S.A. (“Helsinn”) and Roche Palo Alto LLC (“Roche”)
`
`(collectively, “Patent Owner”), submit the following mandatory notices in
`
`connection with the above-identified proceeding.1
`
`I.
`
`
`Real Party-in-Interest
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), the real parties-in-interest are Helsinn
`
`and Roche, the assignees of record for U.S. Patent No. 9,173,942 (“the ’942
`
`patent”).
`
`II. Related Matters
`Patent Owner identifies the following matters that may be deemed related
`
`pursuant to 37 C.F.R. § 42.8(b)(2).
`
`A. USPTO Proceedings Involving the Patent-at-Issue
`The ’942 patent, which is the subject of this proceeding, is at issue in case
`
`PGR2016-00007.
`
`
`1 A Power of Attorney appointing lead and back-up counsel is being filed
`
`concurrently with these Notices.
`
`1
`
`
`
`
`
`Patent No. 9,173,942
`
`Litigations Involving the Patent-at-Issue and/or Related Patents
`
`B.
`The ’942 patent, or other patents claiming their earliest priority date to the
`
`same provisional application as the ’942 patent (i.e., provisional application no.
`
`60/444,351), are at issue in one or more of the following cases:
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Labs., Ltd. et al.,
`
`Civil Action Nos. 11-3962, 11-5579, 13-5815 (consolidated) (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Labs., Ltd. et al.,
`
`Civil Action No. 12-2867 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Labs., Ltd. et al.,
`
`Civil Action Nos. 14-4274 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Labs., Ltd.,
`
`Civil Action No. 15-8662 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Teva Pharm. USA, Inc. et al.,
`
`Civil Action No. 14-6341 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Teva Pharm. USA, Inc. et al.,
`
`Civil Action No. 15-8663 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Fresenius Kabi USA, LLC et al.,
`
`Civil Action No. 15-7015 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Fresenius Kabi USA, LLC et al.,
`
`Civil Action No. 15-7378 (D.N.J.)
`
`2
`
`
`
`Patent No. 9,173,942
`
`
` Helsinn Healthcare S.A. et al. v. Hospira, Inc. et al.,
`
`Civil Action No. 15-2077 (D.N.J)
`
` Helsinn Healthcare S.A. et al. v. Hospira, Inc. et al.,
`
`Civil Action No. 15-264 (D. Del)
`
` Helsinn Healthcare S.A., et al. v. Exela Pharma Scis., LLC, et al., Civil
`
`Action No. 14-1444 (D. Del)
`
` Helsinn Healthcare S.A. et al. v. Qilu Pharm. Co., Ltd. et al.,
`
`Civil Action No. 15-8132 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Sagent Pharms., Inc. et al.,
`
`Civil Action No. 16-173 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Sagent Pharms., Inc.,
`
`Civil Action No. 16-681 (D.N.J.)
`
`Federal Circuit Proceedings Involving the Patent-at-Issue
`
`C.
`Other patents claiming their earliest priority date to the same provisional
`
`application as the ’942 patent (i.e., provisional application no. 60/444,351), are at
`
`issue in Helsinn Healthcare S.A. et al. v. Teva Pharms. USA, Case No. 16-1284
`
`(Fed. Cir.).
`
`III. Lead and Back-Up Counsel and Service Information
`In accordance with 37 C.F.R. §42.8(b)(3) and (b)(4), Patent Owner identifies
`
`the following lead and back-up counsel and service information:
`
`3
`
`
`
`Patent No. 9,173,942
`
`
`Lead Counsel
`
`Back-Up Counsel
`
`Eric W. Dittmann (Reg. No. 51,188)
`Paul Hastings LLP
`75 East 55th Street
`New York, NY 10022
`Telephone: (212) 318-6000
`Facsimile: (212) 319-4090
`Email: PH-drreddys-helsinn-PGR
`@paulhastings.com
`
`Naveen Modi (Reg. No. 46,224)
`Paul Hastings LLP
`875 15th Street NW
`Washington, DC 20005
`Telephone: (202) 551-1990
`Facsimile: (202) 551-0490
`Email: PH-drreddys-helsinn-PGR
`@paulhastings.com
`
`Back-Up Counsel
`
`Back-Up Counsel
`
`Michael A. Stramiello, Ph.D. (Reg. No.
`67,195)
`Paul Hastings LLP
`875 15th Street NW
`Washington, DC 20005
`Telephone: (202) 551-1958
`Facsimile: (202) 551-0490
`Email: PH-drreddys-helsinn-PGR
`@paulhastings.com
`
`Thomas L. Irving (Reg. No. 28,619)
`Finnegan LLP
`901 New York Ave., NW
`Washington, DC 20001-4413
`Telephone: (202) 408-4082
`Facsimile: (202) 408-4400
`Email: tom.irving@finnegan.com
`
`Back-Up Counsel
`
` Mark E. Waddell (Reg. No. 31,803)
`Loeb & Loeb LLP
`345 Park Avenue
`New York, NY 10154
`Telephone: (212) 407-4127
`Facsimile: (646) 619-4540
`Email: mwaddell@loeb.com
`
`
`
`
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`Patent No. 9,173,942
`
`
`Dated: February 26, 2016
`
`
`
`By: /Eric W. Dittmann/
`Eric W. Dittmann (Reg. No. 51,188)
`Naveen Modi (Reg. No. 46,224)
`Michael A. Stramiello, Ph.D. (Reg. No. 67,195)
`Thomas L. Irving (Reg. No. 28,619)
`Mark E. Waddell (Reg. No. 31,803)
`Counsel for Patent Owner
`
`5
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on February 26, 2016, a copy of the foregoing Patent
`
`Owner’s Mandatory Notices was served by e-mail on the following counsel of
`
`record for Petitioner:
`
`William L. Mentlik (WMentlik.ipr@ldlkm.com)
`Michael H. Teschner (MTeschner.ipr@ldlkm.com)
`Maegan A. Fuller (MFuller.ipr@ldlkm.com)
`
`By:
`
`/Eric W. Dittmann/
`Eric W. Dittmann (Reg. No. 51,188)
`
`
`
`Counsel for Patent Owner
`
`
`
`
`
`
`
`Dated: February 26, 2016